As year-end deadline looms, Congress again calls on DEA to extend telehealth flexibilities
Bipartisan lawmakers say a temporary extension isn’t adequate, and they’re concerned that the draft proposal is “misaligned with Congressional intent” with regard to a registry for the prescribing of controlled substances via telemedicine.
Bipartisan lawmakers say a temporary extension isn’t adequate, and they’re concerned that the draft proposal is “misaligned with Congressional intent” with regard to a registry for the prescribing of controlled substances via telemedicine.
Go to Source
2024-10-16 21:01
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
